Interleukin23 in Systemic Lupus
Recruiting · NCT06713187 · Interventional (participants receive a specific treatment) · Lead sponsor: Sohag University
View the official record on ClinicalTrials.gov →Interventions studied
interleukin 23
What this trial is about
assement of interleukin 23 in serum of patients with systemic lupus erythematosus related interstial lung disease .
Who can take part
Age range
18 Years to 60 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- patients with systemic lupus erythematous and patients with systemic lupus erythematosus with interstial lung disease.
Exclusion criteria
- patients with chest conditions rather than interstial lung disease \&who receiving biological blocking antibodies\& those treated with immunosuppressive drugs.
Where it is running
2 locations listed.
- Sohag university hospital - Sohag, Egypt
- Sohag university - Sohag, Egypt